Skip to content

Public FDA record

Z-1133-2022: INTERTAN 1.5 NAIL 13mm X 42cm 130DEG. Left INTERTAN 1.5 NAIL 13mm X 42cm 130DEG. Right

Recall record Z-1133-2022 for Smith & Nephew Orthopaedics GmbH. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1133-2022
Company in FDA record
Smith & Nephew Orthopaedics GmbH
FDA record creation date
May 25, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Right nails were anodized, marked, and labelled as left nails and vice versa

Source facts

Action
The firm sent out a recall notification letter via email and overnight mail on 04/22/2022. The letter instructs the consignee to check inventory, return affected product, and complete the response form. Distributors were informed to notify their customers of the field action.
Initiated
2022-04-22
Root cause
Under Investigation by firm
Distribution
Distributed nationwide to GA, OH, IN, TX, CO, MO, TN, CA, NC, PA and internationally to Canada, Australia.
Recall number
Z-1133-2022
Recall status
Open, Classified
CDRH record ID
193510
FDA record created
2022-05-25
Recall event number
90118

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗